Pfizer Inc (PFE) Stock Price, Quote & News

Company Profile

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally. It operates in three segments: Biopharma, PC1, and Pfizer Ignite. The company offers internal medicine products, including cardiovascular metabolic diseases products under the Eliquis brand; migraine products under the Nurtec ODT/Vydura and Zavzpret brand; vaccines under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands;...

Industry: Drug Manufacturers - General

Sector: Healthcare

Phone: 212 733 2323

Website: www.pfizer.com

Address:

66 Hudson Boulevard East, New York, United States

reyofhope Aug. 11 at 1:30 PM

$PFE I own the stock but does anyone know why Fauci pleaded the 5th and didn't wanna answer a basic question like what day is it? That was ridiculous.

0 · Reply

La_Parka3 Aug. 11 at 1:18 PM

$BNTX $MRNA $PFE

0 · Reply

GordoHLYK13 Aug. 11 at 1:12 PM

$IGC Yo, $MRNA dont ’t waste your time! 👀 If you’re looking for a biotech with a real near-term catalyst, support $IGC and watch this one closely. IGC has now randomized 160 patients, above the original 146 target, with up to 8 more potentially coming before enrollment officially closes. Q4 2026 topline results for IGC-AD1 are the big catalyst. And management isn’t sitting around waiting for the data—they’re preparing for FDA and EMA regulatory interactions, strengthening biostatistical/AI data capabilities, and brought in OPIS Research to help navigate the European regulatory pathway. If CALMA delivers, IGC could go from micro-cap biotech to a serious pharma-partnership conversation. 🚀 The setup is getting real. $IGC — Q4 is the moment. 🔥 $PFE

0 · Reply

GordoHLYK13 Aug. 11 at 1:10 PM

$IGC what I said !!! 🚨 Fresh news just hit the wires from The Fly! $IGC is getting regulatory-ready as Phase 2 CALMA heads toward enrollment closure and the Q4 topline readout. Key takeaways: * 🧪 160 patients randomized — already above the original 146 target, with up to 8 more expected before enrollment closes. * 📊 Q4 2026 topline data remains the target for IGC-AD1. * 🏛️ FDA & EMA prep is ramping up, with expanded biostatistical and AI data-science capabilities. * 🤝 Big Pharma discussions could follow the unblinded readout. * 🇪🇺 European expansion: IGC engaged global CRO OPIS Research to support its EMA regulatory pathway. That 4:00 AM pre-market activity suddenly looks interesting. 👀 Management isn’t just waiting for data—they’re building the regulatory and partnership infrastructure ahead of the Q4 catalyst. $IGC 🚀 $MRNA $PFE

0 · Reply

NorthOfSouth Aug. 11 at 12:38 PM

$PFE seems odd that PFE moves up just before this azz backwards vaccination mandate???

1 · Reply

TraderDaKing Aug. 11 at 12:20 PM

$GME $PFE $AMC $WEN Big week. ELTP stock has earnings Thursday and a Big Conference Call Friday.

0 · Reply

neversurrender2024 Aug. 11 at 12:14 PM

$PFE such greedy little sheep, investing in your own demise ... good luck!

0 · Reply

PickAlpha Aug. 11 at 11:36 AM

Morning Report | Hormuz reopening talks stall, crude risk premia keep inflation bid $USO.X Hormuz talks stall, crude risk premium $BW guidance reset, stock rips $ASTS miss again, dilution overhang $NVDA courts $500B+ AI infrastructure capital $PFE vaccine order, HHS 90-day review https://open.substack.com/pub/pickalpha/p/morning-report-hormuz-reopening-talks?r=1m2m41&utm_campaign=post&utm_medium=web&showWelcomeOnShare=true

0 · Reply

MissionImpossibl Aug. 11 at 11:31 AM

$BIDU $BABA $JD they have been same price for over two decades or as long as I can remember. You could have owned $PFE $VZ and slept well with 10% annual dividend ! Q: these companies are best among Chinese tech industry, does anyone in China buy these stocks 🇨🇳?? If they are not buying them , why the fk USA retail keep 🔥ing money ?

1 · Reply

Quantumup Aug. 11 at 11:20 AM

Piper Sandler⬆️ $BBIO's PT to $115 from $111, reit'd OW/said w/ Priority Review granted for both BBP-418/encaleret & no advisory committees currently planned for either, it sees a clear regulatory path heading into a pot'l multi-launch period. $ALNY $PFE IONS AZN Wells Fargo⬆️ BridgeBio's PT to $102 from $98, reiterated Overweight and said -- Shares are +8% YTD vs. XBI's +30% despite gaining more certainty around Gx Tafamidis entry and the modest re-rate on CARDIO-Transform failing which may benefit Attruby/stabilizers over Amvuttra in the 1L. We think shares should trade up after CARDIO-Transform's detailed data are presented at ESC (Aug 28-31) as we don't think increased Attruby share has been totally factored in, while multiple near-term launches should drive BBIO's next leg of growth. PT to $102 on updates.

0 · Reply

Pfizer price target lowered to $31 from $35 at Guggenheim

2026-08-06T13:09:00.000Z - 5 days ago

Pfizer’s (PFE) Q2 Earnings Support a Bullish View

2026-08-05T10:45:23.000Z - 6 days ago

Pfizer price target raised to $27 from $26 at BofA

Aug 4, 2026, 10:00 AM EDT - 6 days ago

Pfizer Earnings Call Transcript: Q2 2026

Aug 4, 2026, 10:00 AM EDT - 6 days ago

Pfizer Earnings release: Q2 2026

Aug 4, 2026, 10:00 AM EDT - 6 days ago

Pfizer Slides: Q2 2026

Aug 4, 2026, 10:00 AM EDT - 6 days ago

Pfizer Quarterly report: Q2 2026

2026-08-04T11:39:45.000Z - 7 days ago

Pfizer Stock (PFE) Falls on 2026 Sales Outlook as Cancer Drugs Fuel Q2 Beat

Aug 4, 2026, 7:24 AM EDT - 7 days ago

Pfizer Post Loss on Higher Revenue

Aug 4, 2026, 7:13 AM EDT - 7 days ago

Pfizer tops quarterly estimates, hikes low end of revenue guidance on strength of non-Covid products

Aug 4, 2026, 7:12 AM EDT - 7 days ago

Why Pfizer Stock and This Covid Vaccine Partner Are Falling on Earnings

BNTX

2026-08-04T10:52:17.000Z - 7 days ago

Pfizer reports Q2 adjusted EPS 77c, consensus 68c

Aug 4, 2026, 6:52 AM EDT - 7 days ago

Pfizer beats quarterly profit estimates on strong demand for blood thinner Eliquis

2026-08-04T10:51:36.000Z - 7 days ago

Pfizer backs FY26 adjusted EPS view $2.80-$3.00, consensus $2.95

2026-08-04T10:50:31.000Z - 7 days ago

Pfizer announces expansion of productivity enhancement Initiatives

Aug 4, 2026, 6:45 AM EDT - 7 days ago

Pfizer Reports Second-Quarter Results And Raises Midpoint of 2026 Revenue Guidance

Aug 3, 2026, 8:10 AM EDT - 8 days ago

5 Things to Know Before the Stock Market Opens on Monday

AMD AZN BMY CAT CVS DASH DIS

Jul 30, 2026, 7:48 AM EDT - 12 days ago

Pfizer's oral drug restores skin pigmentation in late-stage vitiligo trials

2026-07-30T11:03:18.000Z - 12 days ago

Pfizer says LITFULO studies meet co-primary endpoints

Jul 30, 2026, 6:45 AM EDT - 12 days ago

Pfizer Announces Positive Topline Phase 3 Results for LITFULO in Patients with Nonsegmental Vitiligo

Jul 29, 2026, 4:30 PM EDT - 12 days ago

European Commission Authorizes Pfizer and BioNTech XFG-adapted COVID-19 Vaccine in the European Union

BNTX

Jul 22, 2026, 4:48 PM EDT - 19 days ago

Pfizer's prostate cancer drug combination gets US FDA priority review

Jul 22, 2026, 4:30 PM EDT - 19 days ago

FDA Grants Priority Review for Pfizer's TALZENNA Plus XTANDI for the Treatment of Metastatic Prostate Cancer

Jul 21, 2026, 7:10 PM EDT - 20 days ago

Trump says generic drugs to face no US tariffs for 2 years before rates of 100% and 200% later

LLY

Jul 16, 2026, 1:39 PM EDT - 25 days ago

Pfizer suspends sales of Premarin vaginal cream in India, citing supply challenges

Jul 10, 2026, 11:23 AM EDT - 4 weeks ago

U.S. FDA Approves PADCEV® plus Keytruda® as Neoadjuvant and Adjuvant Treatment for Muscle-Invasive Bladder Cancer Regardless of Cisplatin Eligibility

Jul 6, 2026, 10:00 AM EDT - 5 weeks ago

Options Corner: PFE Downgrade, Stock Slides Near 52-Week Low

Jun 29, 2026, 4:43 PM EDT - 6 weeks ago

Value stocks beat growth when inflation is high. Here are 13 stocks top newsletters are betting on now.

ABT ADM APD BAC CMCSA CVS DIS

Jun 29, 2026, 1:20 AM EDT - 6 weeks ago

Pfizer, Innovent GLP-1 drugs pass China insurance preliminary review

Jun 24, 2026, 3:52 PM EDT - 6 weeks ago

Pfizer Declares Third-Quarter 2026 Dividend

Jun 24, 2026, 2:10 PM EDT - 6 weeks ago

FDA Approves Pfizer's IBRANCE Regimen for HR+, HER2+ Metastatic Breast Cancer Frontline Maintenance

Jun 24, 2026, 10:51 AM EDT - 6 weeks ago

Pfizer dismissed from US states' drug price-fixing lawsuit

Jun 23, 2026, 12:10 PM EDT - 6 weeks ago

China outpacing Europe in drug innovation and development, Pfizer executive says

Jun 23, 2026, 10:00 AM EDT - 6 weeks ago

Pfizer Invites Public to View and Listen to Webcast of August 4 Conference Call with Analysts

Jun 22, 2026, 4:43 PM EDT - 7 weeks ago

Pfizer's experimental drug misses main goal of lung cancer trial

Jun 22, 2026, 4:30 PM EDT - 7 weeks ago

Pfizer Announces Topline Phase 3 Results for Sigvotatug Vedotin in Previously Treated Metastatic Non-Squamous Non-Small Cell Lung Cancer

Jun 22, 2026, 2:32 PM EDT - 7 weeks ago

Wall Street loves growth stocks — but these 10 ‘losers' are primed to win

ACHR AGCO COF DHI DVN EOG TSN

Jun 18, 2026, 6:52 AM EDT - 7 weeks ago

Pfizer CFO Dave Denton to step down, leave company in August

Jun 18, 2026, 6:45 AM EDT - 7 weeks ago

Pfizer Announces Chief Financial Officer Transition

Jun 10, 2026, 7:56 AM EDT - 2 months ago

Pfizer CEO warns German investment at risk over drug pricing policies

Jun 9, 2026, 2:07 PM EDT - 2 months ago

Want to Avoid the Whipsawing Tech Stocks? Dollar General and 7 Others to Buy.

DG ALGN BBY BIIB CVS VZ

Jun 9, 2026, 9:20 AM EDT - 2 months ago

Trouble Ahead For GLP-1 Drugs As Health Plans Stop Paying

AMGN JNJ LLY MRK NVO

Jun 9, 2026, 3:20 AM EDT - 2 months ago

The space race is coming for pharma: Why drug development is heading to lower Earth orbit

BMY LLY MRK RDW UTHR XBI

Jun 8, 2026, 8:00 AM EDT - 2 months ago

Pfizer Transcript: Goldman Sachs 47th Annual Global Healthcare Conference 2026

Jun 8, 2026, 6:49 AM EDT - 2 months ago

US FDA approves Pfizer's bleeding disorder drug for children

Jun 8, 2026, 6:45 AM EDT - 2 months ago

U.S. FDA Approves Pfizer's HYMPAVZI for the Treatment of Two Additional Hemophilia A or B Patient Populations with Significant Medical Need

Jun 6, 2026, 11:00 AM EDT - 2 months ago

Pfizer Transcript: Study update

Jun 6, 2026, 11:00 AM EDT - 2 months ago

Pfizer Slides: Study update

Jun 6, 2026, 11:00 AM EDT - 2 months ago

Pfizer Press release: Study update

Jun 6, 2026, 9:06 AM EDT - 2 months ago

Pfizer's monthly obesity shot has side-effect profile similar to Wegovy in midstage trial

Jun 6, 2026, 9:00 AM EDT - 2 months ago

Robust Phase 2b Efficacy and Favorable Tolerability Support Monthly Dosing for Pfizer's GLP-1 RA Berobenatide

Jun 4, 2026, 10:00 AM EDT - 2 months ago

Chai Discovery Announces License Agreement with Pfizer to Accelerate Drug Discovery with AI

Jun 4, 2026, 6:40 AM EDT - 2 months ago

Why Pfizer And Eli Lilly Are Betting On This $1.3 Billion AI Drug Discovery Startup

LLY

Jun 3, 2026, 2:00 PM EDT - 2 months ago

Pfizer Transcript: Jefferies Global Healthcare Conference 2026

Jun 1, 2026, 10:00 AM EDT - 2 months ago

Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference

May 31, 2026, 8:00 AM EDT - 2 months ago

Pfizer's BRAFTOVI Regimen Nearly Doubles Median Progression-Free Survival in Metastatic Colorectal Cancer

May 30, 2026, 8:00 AM EDT - 2 months ago

TALZENNA Plus XTANDI Improves Radiographic Progression-Free Survival by More Than 50% in Metastatic Prostate Cancer

May 29, 2026, 8:00 AM EDT - 2 months ago

Seven-Year Analysis from Pfizer's LORBRENA CROWN Trial Shows Longest Progression-Free Survival Reported to Date in Advanced Non-Small Cell Lung Cancer

May 28, 2026, 11:10 PM EDT - 2 months ago

Innovent Biologics shares rise 10% after pact with Pfizer of up to $10.5 billion

May 28, 2026, 7:19 PM EDT - 2 months ago

China's Innovent Biologics, Pfizer strike up to $10.5 billion cancer drug deal

May 28, 2026, 7:00 PM EDT - 2 months ago

Innovent Biologics and Pfizer Enter Global Strategic Collaboration to Accelerate Development of Innovative Oncology Medicines

May 28, 2026, 7:00 PM EDT - 2 months ago

Pfizer and Innovent Biologics Enter Global Strategic Collaboration to Accelerate Development of Innovative Oncology Medicines

May 27, 2026, 10:00 AM EDT - 2 months ago

Pfizer Invites Public to View and Listen to Webcast of Pfizer Discussion at Healthcare Conference

May 20, 2026, 9:00 AM EDT - 2 months ago

Sarah Cannon Research Institute Announces Strategic Oncology Research Collaboration with Pfizer

May 20, 2026, 5:08 AM EDT - 2 months ago

Pfizer's pneumococcal shot shows stronger immune response in mid-stage trial

May 20, 2026, 5:05 AM EDT - 2 months ago

Pfizer Advances Pivotal Pediatric Pneumococcal Vaccine Program Following Strong Positive Phase 2 Results

reyofhope Aug. 11 at 1:30 PM

$PFE I own the stock but does anyone know why Fauci pleaded the 5th and didn't wanna answer a basic question like what day is it? That was ridiculous.

0 · Reply

La_Parka3 Aug. 11 at 1:18 PM

$BNTX $MRNA $PFE

0 · Reply

GordoHLYK13 Aug. 11 at 1:12 PM

0 · Reply

GordoHLYK13 Aug. 11 at 1:10 PM

0 · Reply

NorthOfSouth Aug. 11 at 12:38 PM

$PFE seems odd that PFE moves up just before this azz backwards vaccination mandate???

1 · Reply

TraderDaKing Aug. 11 at 12:20 PM

$GME $PFE $AMC $WEN Big week. ELTP stock has earnings Thursday and a Big Conference Call Friday.

0 · Reply

neversurrender2024 Aug. 11 at 12:14 PM

$PFE such greedy little sheep, investing in your own demise ... good luck!

0 · Reply

PickAlpha Aug. 11 at 11:36 AM

0 · Reply

MissionImpossibl Aug. 11 at 11:31 AM

1 · Reply

Quantumup Aug. 11 at 11:20 AM

0 · Reply

psyens Aug. 11 at 10:43 AM

$PFE woah! How is this going up? Did they acquire Nvidia? I might finally break even after holding dead money since 2023 (we'll call it a sentimental value hold).

1 · Reply

Makingmillions192 Aug. 11 at 10:07 AM

$LEXX Eli Lilly takes weight-loss pill battle global. $LLY $NVO $PFE $AMGN About to heat up here 🔥

0 · Reply

La_Parka3 Aug. 11 at 9:23 AM

$BNTX $MRNA $PFE There are losers before and after the pandemic. The only difference is after the pandemic, many losers have 84 year old Dr. Fauci as their convenient excuse for every miserable thing that is wrong in their life. We cannot rule out that quite a few people were negatively affected by the stupid unnecessary now erased mandate but 99% of those complaining are just losers who just want to get angry at something. Even the 1% who really have a reason to get upset are barking at the wrong tree if they are angry here as companies are not policy makers. But anti-vaccine rhetorics are not working anymore as the stock price of vaccine companies are not even responding to any of the nonsense.

0 · Reply

Samishere Aug. 11 at 8:02 AM

$BNTX $MRNA $PFE

0 · Reply

Samishere Aug. 11 at 8:00 AM

$PFE

0 · Reply

jrh34 Aug. 11 at 3:04 AM

$PFE $30 print coming.

0 · Reply

neversurrender2024 Aug. 11 at 1:47 AM

$PFE no mrna vaccines for me! https://x.com/FiveTimesAugust/status/2082491516140855547

1 · Reply

Spicy_Trade Aug. 11 at 1:23 AM

Pfizer, Inc. ( $PFE ) SpicyTrade - Daily Stock Analysis https://youtu.be/SiTNWGfwS7k?si=7VSg6tX4P8J2tYv8

0 · Reply

EmbraceVolatility Aug. 11 at 1:13 AM

$PFE Again, defies logic.

0 · Reply

LuisBarajas16 Aug. 11 at 12:50 AM

$INO question for those who where here since Covid or understand legal proceedings. Knowing the case that is going on with Dr. Fraudci- they knew how back the safety and efficacy were on the vaccines that were rolled out. Despite knowing this they allowed for mass distribution and enforcement. Politicians pocketed money since they were invested heavily in $MRNA $PFE . So their interest for these companies to succeed was at stake. …..CONFLICT OF INTEREST……. Can one start a class action against them? Knowing that we were one of the forefront companies? With a safer and effective vaccine?

3 · Reply

GordoHLYK13 Aug. 11 at 12:19 AM

$IGC IGC is lining up for a major catalyst: CALMA has hit its full 146-patient enrollment target and is advancing toward topline analysis. Add its AI platform, Alzheimer’s-focused pipeline, and growing investor attention—and the setup is getting VERY interesting. 🚀🧠 $IGC $PFE $MRNA

0 · Reply

taxplanr Aug. 11 at 12:17 AM

$BNTX $MRNA $PFE Germany geeting it done https://childrenshealthdefense.org/defender/german-court-rules-biontech-release-covid-vaccine-injury-records/?utm_source=cc&utm_medium=email&utm_campaign=defender&utm_id=20260810

0 · Reply

Market Cap	152.52B
Revenue (ttm)	62.58B
Net Income (ttm)	7.77B
EPS (ttm)	N/A
PE Ratio	8.59
Forward PE	8.81
Profit Margin	12.42%
Debt to Equity Ratio	0.71

Volume	49,786,700
Avg Vol	44,586,855
Day's Range	N/A - N/A
Shares Out	5.70B
Stochastic %K	95%
Beta	0.34
Analysts	Sell
Price Target	$28.60